About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Alterations in Four Main Genes Linked To Patient Survival

by Bidita Debnath on November 5, 2017 at 10:53 PM
Font : A-A+

Alterations in Four Main Genes Linked To Patient Survival

The pancreas secretes enzymes that aid digestion and hormones that help regulate the metabolism of sugars. This type of cancer is often detected late, spreads rapidly and has a poor prognosis. Researchers have found that alterations in four main genes are responsible for how long patients survive with pancreatic cancer.

"The research helps us to understand how the molecular features of pancreatic cancer impact prognosis on an individual level and gives us more facts to guide patients, and importantly, to design future research studies," said study co-author Aram Hezel, Medical Oncology at University of Rochester.

Advertisement


For the study, published in the Journal JAMA Oncology, involved 356 patients who all had pancreatic adenocarcinoma that could be surgically removed.

Adenocarcinoma is by far the most common type of pancreas tumour.

Ninety of the patients were treated at the University of Rochester Medical Centre's Wilmot Cancer Institute; the others at Dana Farber/Brigham and Women's Cancer Centre in Boston and Stanford Cancer Institute.
Advertisement

In all cases after the tumours were removed, scientists extracted DNA from the cancerous tissue and nearby normal tissue and conducted next-generation DNA sequencing on the specimens.

The analysis centred on the activity of the KRAS, CDKN2A, SMAD4, and TP53 genes.

Results showed that patients who had three or four of the altered genes had worse disease-free survival (the time between surgery and when the cancer returns), and overall survival (from surgery to death), compared to patients with a single or two altered genes.

Pancreatic cancer is aggressive and generally has poor survival odds.

"Patients who can undergo surgery as part of treatment often survive longer and some patients fare best when they can receive chemotherapy prior to surgery. But having customised, molecular information will provide an even greater understanding of how the disease is likely to progress in each patient," Hezel noted.

Source: IANS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Weaver Syndrome 

Recommended Reading
Pancreatic Cancer Survival Depends on Four Genes
Adenocarcinoma is the most common type of pancreas tumor and the chances of a patient's survival ......
New Compound may Help Kill Pancreatic Cancer Stem Cells
The almost uniform and threatening lethality of pancreatic cancer originates in its stem cells. ......
Potential Therapies For Pancreatic Cancer Found
A protein-cleaving enzyme called FAP, for fibroblast activation protein is responsible for ......
New Research may Help Scientists Combat Pancreatic Cancer
Understanding tumor microbiology will help researchers improve the existing chemotherapies ......
Weaver Syndrome
Weaver syndrome is a genetic disorder in which children show accelerated bone growth, advanced bone ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use